Terutroban sodium

N/A

Report date: 2025/05/12 16:57:56
NME

Base Information

Drug NameTerutroban sodium
Drug Alias Name特鲁曲班S-18886Terutroban sodiumS-18204
ClassificationSmall molecules
Mechanisms of ActionThromboxane A2 receptor antagonists
TargetsThromboxane A2 receptor
Therapy Area/IndicationsThromboembolismAtherosclerosisDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsThromboembolismAtherosclerosisDiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksWikipedia